<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 333 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page332.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=333">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 333 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 333</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=333"><img src="../thumb/333.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>296 / 2020-04                                                  Endocrine System - 19.1.2.2 / 19.1.3 / 19.2








   Dosage: Assess hydrat.status & ren.funct bef. init. treatm., do not   poglycaem., meds.depend.on thresh.conc.for effic. such as antibiot.  Drug interactions: Insulin reacts.antagonistically, indomethacin
                    2
   init.treatm if eGFR &lt; 60 mL/ min/1,73 m  (or creatin.clear.&lt; 60 mL/  to be admin.at least 1 hr bef.ther., skelet.defects/cleft palate/reduc.  may prev.raise in bld.gluc./produc. hypoglycaem., warfarin’s anti-
   min) &/ in vol. deplet./acidot pts.  foet. growth with high Byetta dos.dur.gestat.  coag.eff.incr., tempor. incr.in pulse and BP with ß-block.
   Recomm.start.dos.: 10 mg once dly.which if tolerat. may be incr.
   to 25 mg once dly in pts.req. addit. glycaem.contr.  Drug interactions: Decr.Lovastatin AUC & C max , lovastatin t max
                                delay  , t max delay observ.when digox./ lisinopril/warfarin admin.
   Contraindications: Treatm.of type 1 diabet. mellit./ treatm.of   30 mins.aft.exenatide, extent & rate of absorpt.of oral.admin.
   ketoacidos., mod.& sev.ren. impairm. (creatin.clear.&lt; 60 mL/min),   meds. reduc., incr.hypoglycaem.incid.with concom. sulphonylu- 19.3  Thyroid
   end state ren. dis./dialys., pregn.& lactat.  rea, INR incr.with warfar., poss.alt.ren. funct.with concom.ACE-  EUTHYROX (MDR Listing)
   Side effects: Metabolic acidosis incl.ketoacidos. with atypic.  inhibits./NSAID/diuret.
   presentat., UTI & genit. infects., hypoglycaemia (when used with   See also MDR page 222.  ELTROXIN (Aspen Pharmacare)
   sulphonylurea/ insul.), weight loss, incr.ser.lipids, vol.deplet., prurit.,   Pharmacare[P/S]
   glycosur., incr.urinat., dysur., ketonur., dehydrat., incr.bld creatin./  VICTOZA, Novo Nordisk [P/S]  Levothyroxine sod.
   haematocrit., decr.GFR, thirst, urosepsis, pyleonephrit.  Liraglutide  Indications: Hypothyroid.
   Warnings and special precautions: Pts. present. with S&S   Indications: Adjunct to diet & exerc.to achiev. glycaem.contr.in   (S3) NEW FORMULATION TABS, 47/21.3/0614, 0615, 0616,
   incl.naus./vomit./abdom.pain/ malaise/ shortn.of breath should   type 2 diab.mellit., as monother. or combin.ther.with one or more   0618, 0624
   be assess.for metabol. acidos.even if bld.gluc.levs.&lt;11 mmol/L   oral antidiab. meds.when inadeq.contr. with prev.ther.  723167-001: 25 µg, 30, R20,74
   & treatm.discont.& prompt.managm., predispos. facts. for me-  (S4) SOL FOR INJ, 43/21.13/0781. 6 mg/ml  723168-001: 50 µg, 30, R35,26
   tabol.acidos.incl.insul.dos.reduct./ reduc. calor.intake/reduc.  716645-001: 2x3 ml pre-fill.multidos.pen, R1 565,48  723170-001: 75 µg, 30, R42,32
   fluid intake/incr.insul. req. due to infect/illn./surg./alcoh.abuse,   716645-002: 3x3 ml pre-fill.multidos.pen, R2 348,23  723171-001: 100 µg, 30, R44,63
   progress. incr.in bld.& urine keton.& progress.incr.in metabol.   Dosage: Monother: Admin.SC once dly.at any time. Init.0,6 mg   723172-001: 200 µg, 30, R86,87
   acidos.pos.indicat.of ketoacidos. developm. irrespect.of bld.gluc.  for at least one wk., thereaft. incr. to 1,2 mg. Based on clinic.re-  Dosage: Take bef.1  meal of the day. Indiv.& monit. reg. Pts.&gt;50
                                                                       st
   levs., monit.bld./ urine keton.& bld.pH reg., underly.mechan.for   spons.& aft.at least one wk.may be incr.to 1,8 mg to achiev.max.effic.  yrs.with/ without card.dis. clinic. respons.probably a more accept.
   SGLT 2 inhibit.-assoc ketoacidos.not est., atypic. metabol. acidos.  Combinat.ther: May be add.to exist.metformin or combin.met-  dos.criter. than ser.lev.
   may pres.in simil.mann.to ketoacidos., incr.in haematocrit can be   formin & thiazolidinedione combin.ther. Current dos.of these meds.  Adults: Init 50-100 µg dly. Adjust 3-4 wk.interv.by 50 µg until norm.
   expect., not for use in weight contr.progs., predispos.factors for   may be contin.unchang.  metabol.steadily maint.poss. requir. dos.up to 100-300 µg dly.
   ketoacidos. incl.low beta-cell funct.reserve result. from pancreat.  May be add.to exist.sulphonylur.or metformin & suphonylur. com-  Pts.&gt;50 yrs: Init 50 µg dly. Adjust 3-4 wk.interv.by 50 µg until stable
   disords., not recomm.in pts. &gt; 85 yrs.& childr.&lt;18 yrs., incr.risk of   bin.ther. Reduc.sulphonylur.dos.by approx.half to mimim.unaccept.  thyrox.lev.attain. Fin.dos.up to 50-200 µg dly.
   hypoglycaem. with concom.insul.secretagog.e.g.sulphonylur./ in-  hypoglycaem.risk.  Pts.&gt;50 yrs.with card.dis: Init 25 µg dly.or 50 µg on altern.days.
   sul., assess.ren.funct.prior & periodic.dur. treatm., pts.with known   Contra-indications: Not for use in type 1 diab. mellit./ diab.keto-  Adjust at 4 wk.interv.by 25 µg until stable thyrox.lev.attain. Fin.dos.
   CV dis./hypotens.hist.& pts. on anti-hypertens./diuret.ther., elderly   acidos., not for IM/IV admin., pregn., lactat., do not mix.with other   up to 50-200 µg dly.
   esp.≥ 75 yrs., caref.monitor.vol.status & electrol.in condits. lead to   meds. eg.infus. fluids due to degradat.risk, mod./sev. ren.impairm.  Paeds: Maint.dos: 100-150 µg/m body surf.area. Dos. depends on
                                                                            2
   fluid loss.recomm., tempor. interrupt. treatm until fluid loss correct.,   incl.end-stage ren.dis.pts., no studies in pts.und.18 yrs.  age, weight and condit.being treat. Infts.should be giv.tot.dly.dos.at
   consid. treatm. interrupt.with complicat.UTIs., glycaem. contr. can-  Side-effects: URTI, bronchit., gastro-enterit., osteomyelit., papillary   least 30 min. bef. 1  meal of day. Monit.regul.
                                                                      st
   not be assess.using urine gluc.monitor.or 1,5 AG bld.assay., sev.  thyroid/prostate/breast Ca, thrombocytopen., hypoglycaem.esp.in   Congen.hypothyroid.in infts: Init.recomm.dos.in neonat./infts.
   hepat.impairm., lact.intol.  combin.with sulphonylur., anorex., decr.appet., dehydrat., headache,   where rapid replacem.important: 10-15 µg/kg body weight per
   Interactions: Diuret.eff.of thiaz./loop diurets. poss. enhanc.& risk   CVA, syncope, cataract, incr.heart rate, card.disords. incl. MI/ coron.  day for 1  3 mnths., then adj.dos.indiv.accord.to clin.finds.& thyr.
                                                                  st
   of dehydrat./hypotens.incr.  artery dis./atrial fibrillat./CCF/ supraventric.tachycard., pulm. embol.,   horm/TSH val.
   See also MDR page 268.       GI disturbs.incl.GORD & eructat., appendicit. with perforat., inguin.
                                hern., pancreatit. incl.necrotis.pancreatit., intervert.disc protrus., os-  Acquir.hypothyroid.in childr: Init.recomm.dos: 12,5 - 50 µg per
                                teoarthrit., inj.site reacts., chest pain, malaise, fall, anaphylact.react.,   day. Incr.dos.grad.every 2-4 wk. accord. to clin.finds.& thyr.horm/
                                                              TSH val.until full replacem.dos.reach.
   19.1.3   GLP-1 agonists      skin rash, uritcar., prurit., ac.ren.fail., ren.impairm.  Juven.myxoed.in childr.: Init.recomm.dos: 25 µg dly. with 25 µg
                                Special precautions: Limit.exper.in CHF Class I-II NYHA & no ex-
                                                              increm.every 2-4 wks.until mild sympts. of hyperthyroid.appear,then
   BYETTA (MDR Listing)         per.in class.III-IV, not recomm.in pts. with inflamm.bowel dis./diab.  reduc. slightly.
                                gastropares., cross. placenta in rabbits, reproduct.toxic.in animals,
   BYETTA, Astra Zeneca &       treatm. to be discont.if a woman wish.to becom pregn./pregn.oc-  Contraindications: Untreat.hyperthyroid./adren. insuff./ pituit.
                                                              insuff., thyrotoxicos., treatm.not to be initiat.in ac.MI/myocardit./
   Exenatide                    curs, excret.in milk of lactat.rats, bld.gluc.self-monit.advis.when init.
   Indications: Add-on ther.in type 2 diab.mellit. inadeq.control.by   ther.with concom. sulphonylur., GI sympts.usuall.dimin.with contin.  pancardit.
                                                              Side effects: Angin.pain, palpit., skelet.musc. cramps., thyr.
   lifestyle modificat.& other oral antidiabet.ther., add-on ther.to bas.  treatm., poss.anti-liraglutide antibody developm., warn of S&S of
   insul.with/ without other oral antidiab.ther.in adults where adeq.  ac. pancreatit.& discont. ther.if susp., reduc.concom.sulphonylur.   storm,hypersens.reacts.incl.skin rash / prurit./eosinophil./fev./
   glycaem.control with these agents not achiev.  dos. to reduc.hypoglycaem.risk, limit.exper.in pts. with hepat.im-  liv.dysfunct.,hyper.-/ hypothyroid., heat intol., flush., incr.appet.,
   (S3) SOL FOR INJ, 41/34/0068, 0069  pairm., pre-exist.thyroid dis.   excitabil., restlessn., insomn., confus., agitat., headache, trem, seiz.,
   711678-001: 5 µg, 1x1,2 dispos.pen inj, R325,69  Drug interactions: Incr.hypoglycaem.risk with concom.sulphonylur.  cephalalg., pseudotum. cerebri, card.dysrhythm., tachycard., heart
   711684-001: 10 µg, 1x2,4 dispos.pen inj, R651,40           fail., MI, incr.BP, dyspn., GI disords., sweat., hair loss, musc.weakn.,
   Dosage: Do not admin.by IV/IMI. Admin.as separ. inj.from bas.insul.  decr.bone miner.dens., excess.dos. may result in craniosynostos. in
   apart. Do not admin.aft. meals. Cont.with next sched.dos.if inj.miss.  19.2
   Admin.60 min.bef.two main meals of the day approx. 6 hrs.or more   Anti-hypoglycaemic  infts& prem. clos. of epiphyses in childr.with compromis.adult height,
                                                              menstr.irreg., impair.fertil., fatig., excess.weight loss.
   Do not mix. with other parenteral med. Init: 5 µg SC 2xdly. for at least   Warnings and special precautions: Excl./treat coron. insuffic/
   1 mnth. Thereaft.may be incr.to 10 µg SC 2xdly.  agents    ang.pect./arterioscleros./ hypertens./ pituit.insuffic./adren.insuf-
   Contraindications: Ren.impairm.with creatin. clear. &lt;30 ml/min./  fic./thyr. auton. bef.start.ther., freq.check thyr.horm.param & avoid
   end-stage ren.dis., no studies in sev. GI dis.incl.gastroparesis. GI   GLUCAGEN HYPOKIT, Novo Nordisk [P/S]  any med.-induc.hyperthyroid.in pts.with coron. fail./card.insuffic./
   dysmotility, GI anatomic. obstruct., pregn., lactat., no pharmacoki-  Glucagon HCl.  tachycard.dysrhythm., 
determ. cause of second.hypothyroid.bef.
   net. study in ac./chron.hepat.insuffic., safety & effectiven.not est.  Indications: Sev.hypoglycaem.if adeq.dextr.not effect. /not avail.,   giv. replacem. ther.& commenc.replacem.treatm.of compensat.
   in pts.und.18 yrs.           decr.GI motility in endoscopy & radiography of GIT.  adren.insuffic.if necess., suspect.thyr. auton., postmenopaus.wom.
   Side effects: Alt.ren.funct.incl.ren.impairm./ worsen. chron.ren.fail.,   (S4) INJ. Y/21.11/301. 1 mg/ml  with hypothyroid.& incr. risk of osteoporos., titrate dos.careful.&
   ac.pancreatit., necrotis./ haemorrh. pancreatit.& sometimes death,   821365-002: 1 mg+solvent, R449,22  monit. dur.init.titrat.per.to avoid conseq.of under-/over-treatm.,
   hypoglycaem. with metformin & a sulphonylur., decr. appetite, dehy-  Dosage: Use immed.aft.preparat. Not for IV infus. When con-  panhypopituitar.& other causes pre-dispos. to adren.insuffic.may
   drat., decr.weight, CNS effs., headache, dizzin., GI disturbs.incl.N&V/  sciousn.regain.give food rich in carbohydr./ IV gluc.to restore liv.  react.unfav.& corticoster. ther.advis.bef.admin.thyroxine, elderly,
   eructat./ GORD/ abdom.distens., hyperhidros., inj.site reacts., rash,   glycogen & prev. second. hypoglycaem.  myocard. insuffic., MI./ischaem., diabet.mellit./ insipid., esp.import.
   prurit., urticar., angioed., feel.jittery, asthen., hypersens./anaphylact.  Diabet.hypoglycaem: 1 mg SC/IM/IV  to individ.dos.& monit.dos.in childr. with hypothyroid., adv.parents
   reacts., anti-exenatide antibody develop.but titres dimin.over time   Terminat.of insulin coma: 1 mg. Pt.to be aroused as quick.as   of childr. receiv. treatm.that trans.part.hair loss may occ.dur. first
   remain.low over 82 wks.dimin.glycaem. respons. poss.in pts.with   poss.as prolong.hypoglycaem. reacts.may result in cortic.damage.  few mnths.with.likely subseq.regrowth, bld. sug. lev.rais.& stabil.
   high.titre antibod., high. inj. site reacts.with anti-exenatide antibod.   Endoscopy/GIT radiography: 0,2 mg (endoscopy) to 1,2 mg (GIT   of pts.receiv.antidiabet. meds. poss.upset., monit.INR with warfar.,
   developm., incr.bld./ser.creatin., alopec.  radiography) accord. to techniq.& pts.respons.  poss. false. low conc.of T 4/T 3 with some NSAIDs., pregn, excret.
   Warnings and special precautions: Not for use in type 1 diab.  Contraindications: Phaeochromocyt.  in breast milk & reg.thyr.funct.monit. advis. in both mother & inft.
   mellit.or diabet.ketoacidos.treatm., IV/IM inj.not recomm., oral   Side effects: Hypersens.reacts.incl.anaphylact. react., second.  Drug interactions: Act.of warfarin.enhanc., stabil. of antidiabet.
   meds.requir.rapid GI absorpt.as gastric emptying slow., concom.   hypoglycaem., hypogylcaem.coma, brady-/tachycard., hypo-/hy-  agents upset, phenyt.lev.poss. incr., metabol.enhanc.by carbam-
   thiazolidinediones/d-phenylalanine derivat./ meglitinides or alpha-  pertension, N&V, abdom.pain  azep./phenyt.& may displace thyrox.from plasma prot., recept.
   glucosidase inhibit.not stud., incr. INR & assoc.bleed.with concom.  Warnings and special precautions: As adjunct to endoscopy   sensitiv. to catecholam.incr.incl.accelerat.respon. to TADs, reduc.
   warfar., advise pts.of S&S of ac.pancreatit.& discont.if pancreatit   & radiography of GIT in diabet.pts., card.dis., admin.oral carbohydr.   GI absorpt.with concom. cholestyram., absorpt.decr.with antacids/
   suspect., the report.weight loss of 1,5 kg/wk.may have harmf.con-  to restore liv. glycogen aft.response to prevent hypoglycaem., in-  PPIs/ cimetidine/bile acid sequestr.e.g.colestipol/cation exch.resins
   seq., to reduc.incr. hypoglycaem.incid.report.with concom. sulpho-  sulinoma/glucagonoma as acts antagonistic. towards insulin, not   e.g. kexalate/sucralfate/calc.carbon./ ferr. sulph.(separ. admin.by 4-5
   nylurea consid.reduc.sulphonylurea dos., ongoing eval.of concom.  effect.in pts.with mark.deplet. of liv.glycogen stores (eg. starvat.,   hrs.)incr.dos. requirm. with concom.OCs/ oestrog./tamoxifen/ clo-
   bas.insul.dos.& consid. reduc. bas.insul.dos.in pts.at incr.risk of hy-  adren insuffic., chron.hypoglycaem)  fibrate/ methadone/5-fluorourac./imatinib/ amiodarone/ ritonavir/
                        S4 JARDIANCE ®  10 mg: Each film-coated tablet contains empagliflozin 10 mg. Reg. No. 48/21.2/1380. S4 JARDIANCE ®  25 mg: Each film-coated tablet contains empagliflozin 25 mg.
                        Reg. No. 48/21.2/0411. For full prescribing information refer to the professional information approved by the Regulatory Authority. Applicant details: Ingelheim Pharmaceuticals (Pty) Ltd,
                        407 Pine Ave, Randburg. Tel: +27 (011) 348-2400. Cpy. Reg. No. 1966/008618/07. BI Ref. No. PC-ZA-100408. Expiry date: August 2021.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page332.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page328.html">328</a>&nbsp;&nbsp;&nbsp;<a href="page329.html">329</a>&nbsp;&nbsp;&nbsp;<a href="page330.html">330</a>&nbsp;&nbsp;&nbsp;<a href="page331.html">331</a>&nbsp;&nbsp;&nbsp;<a href="page332.html">332</a>&nbsp;&nbsp;&nbsp;<a href="page333.html">333</a>&nbsp;&nbsp;&nbsp;<a href="page334.html">334</a>&nbsp;&nbsp;&nbsp;<a href="page335.html">335</a>&nbsp;&nbsp;&nbsp;<a href="page336.html">336</a>&nbsp;&nbsp;&nbsp;<a href="page337.html">337</a>&nbsp;&nbsp;&nbsp;<a href="page338.html">338</a>
             </td>
             <td width="35%"><a href="page334.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page334.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
